nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP1A2—Carmustine—malignant glioma	0.265	0.569	CbGbCtD
Clonidine—CYP3A4—Temozolomide—malignant glioma	0.201	0.43	CbGbCtD
Clonidine—Meningitis—Carmustine—malignant glioma	0.00945	0.0497	CcSEcCtD
Clonidine—Skin hyperpigmentation—Carmustine—malignant glioma	0.00616	0.0324	CcSEcCtD
Clonidine—Hyperaesthesia—Temozolomide—malignant glioma	0.00451	0.0237	CcSEcCtD
Clonidine—Endocrine disorder—Temozolomide—malignant glioma	0.00427	0.0224	CcSEcCtD
Clonidine—Diclofenac—CYP2C18—malignant glioma	0.00407	0.288	CrCbGaD
Clonidine—Diclofenac—CXCL8—malignant glioma	0.00389	0.276	CrCbGaD
Clonidine—Respiratory failure—Temozolomide—malignant glioma	0.00361	0.0189	CcSEcCtD
Clonidine—NISCH—telencephalon—malignant glioma	0.00359	0.0424	CbGeAlD
Clonidine—Influenza like illness—Temozolomide—malignant glioma	0.00344	0.0181	CcSEcCtD
Clonidine—Gynaecomastia—Carmustine—malignant glioma	0.00328	0.0172	CcSEcCtD
Clonidine—Dry eye—Temozolomide—malignant glioma	0.00327	0.0172	CcSEcCtD
Clonidine—Diclofenac—CYP2B6—malignant glioma	0.00302	0.214	CrCbGaD
Clonidine—Ear pain—Temozolomide—malignant glioma	0.00301	0.0158	CcSEcCtD
Clonidine—ADRA1D—telencephalon—malignant glioma	0.003	0.0354	CbGeAlD
Clonidine—Nasal congestion—Temozolomide—malignant glioma	0.00282	0.0148	CcSEcCtD
Clonidine—NISCH—medulla oblongata—malignant glioma	0.00282	0.0333	CbGeAlD
Clonidine—Thirst—Temozolomide—malignant glioma	0.0027	0.0142	CcSEcCtD
Clonidine—SLC22A3—embryo—malignant glioma	0.00266	0.0314	CbGeAlD
Clonidine—NISCH—midbrain—malignant glioma	0.00258	0.0304	CbGeAlD
Clonidine—NISCH—spinal cord—malignant glioma	0.00252	0.0297	CbGeAlD
Clonidine—Liver function test abnormal—Carmustine—malignant glioma	0.00246	0.0129	CcSEcCtD
Clonidine—Breast disorder—Temozolomide—malignant glioma	0.00232	0.0122	CcSEcCtD
Clonidine—SLC22A1—telencephalon—malignant glioma	0.00226	0.0267	CbGeAlD
Clonidine—SLC6A2—brainstem—malignant glioma	0.00209	0.0246	CbGeAlD
Clonidine—Dysuria—Temozolomide—malignant glioma	0.00208	0.0109	CcSEcCtD
Clonidine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00207	0.0108	CcSEcCtD
Clonidine—Pollakiuria—Temozolomide—malignant glioma	0.00205	0.0108	CcSEcCtD
Clonidine—Erectile dysfunction—Temozolomide—malignant glioma	0.00205	0.0107	CcSEcCtD
Clonidine—Depression—Carmustine—malignant glioma	0.00204	0.0107	CcSEcCtD
Clonidine—Weight increased—Temozolomide—malignant glioma	0.00202	0.0106	CcSEcCtD
Clonidine—NISCH—cerebellum—malignant glioma	0.00199	0.0235	CbGeAlD
Clonidine—Urinary tract infection—Carmustine—malignant glioma	0.00199	0.0105	CcSEcCtD
Clonidine—Diclofenac—PTGS1—malignant glioma	0.00199	0.141	CrCbGaD
Clonidine—Depression—Temozolomide—malignant glioma	0.00198	0.0104	CcSEcCtD
Clonidine—ADRA1A—brainstem—malignant glioma	0.00194	0.0229	CbGeAlD
Clonidine—Urinary tract infection—Temozolomide—malignant glioma	0.00193	0.0101	CcSEcCtD
Clonidine—SLC6A2—telencephalon—malignant glioma	0.00185	0.0219	CbGeAlD
Clonidine—Hallucination—Carmustine—malignant glioma	0.00183	0.00962	CcSEcCtD
Clonidine—Hypoaesthesia—Carmustine—malignant glioma	0.00183	0.00962	CcSEcCtD
Clonidine—Hepatitis—Temozolomide—malignant glioma	0.00178	0.00934	CcSEcCtD
Clonidine—Hypoaesthesia—Temozolomide—malignant glioma	0.00177	0.0093	CcSEcCtD
Clonidine—Hallucination—Temozolomide—malignant glioma	0.00177	0.0093	CcSEcCtD
Clonidine—ADRA1B—central nervous system—malignant glioma	0.00174	0.0206	CbGeAlD
Clonidine—ADRA1A—telencephalon—malignant glioma	0.00172	0.0203	CbGeAlD
Clonidine—Eye disorder—Carmustine—malignant glioma	0.00172	0.00903	CcSEcCtD
Clonidine—SLC22A5—retina—malignant glioma	0.00171	0.0202	CbGeAlD
Clonidine—ADRA1D—central nervous system—malignant glioma	0.0017	0.0201	CbGeAlD
Clonidine—SLC22A4—spinal cord—malignant glioma	0.00166	0.0196	CbGeAlD
Clonidine—Eye disorder—Temozolomide—malignant glioma	0.00166	0.00873	CcSEcCtD
Clonidine—Tinnitus—Temozolomide—malignant glioma	0.00166	0.00871	CcSEcCtD
Clonidine—Cardiac disorder—Temozolomide—malignant glioma	0.00165	0.00867	CcSEcCtD
Clonidine—Arrhythmia—Carmustine—malignant glioma	0.00164	0.00864	CcSEcCtD
Clonidine—ADRA2C—telencephalon—malignant glioma	0.00164	0.0194	CbGeAlD
Clonidine—Alopecia—Carmustine—malignant glioma	0.00163	0.00854	CcSEcCtD
Clonidine—NISCH—brain—malignant glioma	0.00162	0.0191	CbGeAlD
Clonidine—Angiopathy—Temozolomide—malignant glioma	0.00161	0.00848	CcSEcCtD
Clonidine—Mental disorder—Carmustine—malignant glioma	0.00161	0.00847	CcSEcCtD
Clonidine—Mediastinal disorder—Temozolomide—malignant glioma	0.0016	0.00842	CcSEcCtD
Clonidine—Erythema—Carmustine—malignant glioma	0.0016	0.00842	CcSEcCtD
Clonidine—Alopecia—Temozolomide—malignant glioma	0.00157	0.00826	CcSEcCtD
Clonidine—Mental disorder—Temozolomide—malignant glioma	0.00156	0.00818	CcSEcCtD
Clonidine—Erythema—Temozolomide—malignant glioma	0.00155	0.00813	CcSEcCtD
Clonidine—Vision blurred—Carmustine—malignant glioma	0.00151	0.00793	CcSEcCtD
Clonidine—ABCB1—blood vessel—malignant glioma	0.0015	0.0177	CbGeAlD
Clonidine—Tremor—Carmustine—malignant glioma	0.0015	0.00788	CcSEcCtD
Clonidine—Agitation—Carmustine—malignant glioma	0.00147	0.00773	CcSEcCtD
Clonidine—Vision blurred—Temozolomide—malignant glioma	0.00146	0.00766	CcSEcCtD
Clonidine—SLC6A2—medulla oblongata—malignant glioma	0.00145	0.0172	CbGeAlD
Clonidine—Tremor—Temozolomide—malignant glioma	0.00145	0.00762	CcSEcCtD
Clonidine—Ill-defined disorder—Temozolomide—malignant glioma	0.00144	0.00755	CcSEcCtD
Clonidine—Agitation—Temozolomide—malignant glioma	0.00142	0.00747	CcSEcCtD
Clonidine—Angioedema—Temozolomide—malignant glioma	0.00142	0.00743	CcSEcCtD
Clonidine—Malaise—Temozolomide—malignant glioma	0.0014	0.00733	CcSEcCtD
Clonidine—ADRA1B—brain—malignant glioma	0.00138	0.0163	CbGeAlD
Clonidine—Palpitations—Temozolomide—malignant glioma	0.00137	0.00719	CcSEcCtD
Clonidine—Chest pain—Carmustine—malignant glioma	0.00136	0.00716	CcSEcCtD
Clonidine—Anxiety—Carmustine—malignant glioma	0.00136	0.00714	CcSEcCtD
Clonidine—ADRA1D—brain—malignant glioma	0.00135	0.016	CbGeAlD
Clonidine—Cough—Temozolomide—malignant glioma	0.00135	0.0071	CcSEcCtD
Clonidine—Confusional state—Carmustine—malignant glioma	0.00132	0.00693	CcSEcCtD
Clonidine—SLC22A4—cerebellum—malignant glioma	0.00132	0.0156	CbGeAlD
Clonidine—Arthralgia—Temozolomide—malignant glioma	0.00132	0.00692	CcSEcCtD
Clonidine—Anxiety—Temozolomide—malignant glioma	0.00131	0.0069	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00131	0.00688	CcSEcCtD
Clonidine—ADRA2A—telencephalon—malignant glioma	0.00131	0.0154	CbGeAlD
Clonidine—Oedema—Carmustine—malignant glioma	0.00131	0.00687	CcSEcCtD
Clonidine—Discomfort—Temozolomide—malignant glioma	0.0013	0.00684	CcSEcCtD
Clonidine—Infection—Carmustine—malignant glioma	0.0013	0.00682	CcSEcCtD
Clonidine—Dry mouth—Temozolomide—malignant glioma	0.00129	0.00677	CcSEcCtD
Clonidine—ADRA2C—medulla oblongata—malignant glioma	0.00129	0.0152	CbGeAlD
Clonidine—SLC22A1—central nervous system—malignant glioma	0.00128	0.0152	CbGeAlD
Clonidine—Thrombocytopenia—Carmustine—malignant glioma	0.00128	0.00672	CcSEcCtD
Clonidine—Tachycardia—Carmustine—malignant glioma	0.00128	0.0067	CcSEcCtD
Clonidine—Confusional state—Temozolomide—malignant glioma	0.00127	0.00669	CcSEcCtD
Clonidine—Oedema—Temozolomide—malignant glioma	0.00126	0.00664	CcSEcCtD
Clonidine—Infection—Temozolomide—malignant glioma	0.00126	0.00659	CcSEcCtD
Clonidine—Anorexia—Carmustine—malignant glioma	0.00125	0.00655	CcSEcCtD
Clonidine—Nervous system disorder—Temozolomide—malignant glioma	0.00124	0.00651	CcSEcCtD
Clonidine—Thrombocytopenia—Temozolomide—malignant glioma	0.00124	0.0065	CcSEcCtD
Clonidine—SLC22A5—medulla oblongata—malignant glioma	0.00123	0.0146	CbGeAlD
Clonidine—SLC22A3—central nervous system—malignant glioma	0.00123	0.0145	CbGeAlD
Clonidine—Skin disorder—Temozolomide—malignant glioma	0.00123	0.00645	CcSEcCtD
Clonidine—Hypotension—Carmustine—malignant glioma	0.00122	0.00642	CcSEcCtD
Clonidine—Hyperhidrosis—Temozolomide—malignant glioma	0.00122	0.00642	CcSEcCtD
Clonidine—Anorexia—Temozolomide—malignant glioma	0.0012	0.00633	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00119	0.00626	CcSEcCtD
Clonidine—Insomnia—Carmustine—malignant glioma	0.00118	0.00621	CcSEcCtD
Clonidine—ADRA2C—midbrain—malignant glioma	0.00118	0.0139	CbGeAlD
Clonidine—Paraesthesia—Carmustine—malignant glioma	0.00117	0.00617	CcSEcCtD
Clonidine—Dyspnoea—Carmustine—malignant glioma	0.00117	0.00612	CcSEcCtD
Clonidine—Somnolence—Carmustine—malignant glioma	0.00116	0.00611	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00115	0.00605	CcSEcCtD
Clonidine—ADRA2C—spinal cord—malignant glioma	0.00115	0.0136	CbGeAlD
Clonidine—Insomnia—Temozolomide—malignant glioma	0.00114	0.006	CcSEcCtD
Clonidine—CYP2D6—brainstem—malignant glioma	0.00114	0.0135	CbGeAlD
Clonidine—Decreased appetite—Carmustine—malignant glioma	0.00114	0.00597	CcSEcCtD
Clonidine—Diclofenac—PTGS2—malignant glioma	0.00113	0.0805	CrCbGaD
Clonidine—Paraesthesia—Temozolomide—malignant glioma	0.00113	0.00596	CcSEcCtD
Clonidine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00113	0.00593	CcSEcCtD
Clonidine—SLC22A5—midbrain—malignant glioma	0.00113	0.0133	CbGeAlD
Clonidine—Dyspnoea—Temozolomide—malignant glioma	0.00113	0.00592	CcSEcCtD
Clonidine—Somnolence—Temozolomide—malignant glioma	0.00112	0.0059	CcSEcCtD
Clonidine—Constipation—Carmustine—malignant glioma	0.00112	0.00587	CcSEcCtD
Clonidine—Pain—Carmustine—malignant glioma	0.00112	0.00587	CcSEcCtD
Clonidine—SLC22A5—spinal cord—malignant glioma	0.0011	0.013	CbGeAlD
Clonidine—Decreased appetite—Temozolomide—malignant glioma	0.0011	0.00577	CcSEcCtD
Clonidine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00109	0.00573	CcSEcCtD
Clonidine—Fatigue—Temozolomide—malignant glioma	0.00109	0.00572	CcSEcCtD
Clonidine—Pain—Temozolomide—malignant glioma	0.00108	0.00568	CcSEcCtD
Clonidine—Constipation—Temozolomide—malignant glioma	0.00108	0.00568	CcSEcCtD
Clonidine—Feeling abnormal—Carmustine—malignant glioma	0.00108	0.00566	CcSEcCtD
Clonidine—SLC22A4—brain—malignant glioma	0.00107	0.0126	CbGeAlD
Clonidine—Gastrointestinal pain—Carmustine—malignant glioma	0.00107	0.00562	CcSEcCtD
Clonidine—SLC6A2—central nervous system—malignant glioma	0.00105	0.0124	CbGeAlD
Clonidine—Feeling abnormal—Temozolomide—malignant glioma	0.00104	0.00547	CcSEcCtD
Clonidine—Abdominal pain—Carmustine—malignant glioma	0.00103	0.00543	CcSEcCtD
Clonidine—Body temperature increased—Carmustine—malignant glioma	0.00103	0.00543	CcSEcCtD
Clonidine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00103	0.00543	CcSEcCtD
Clonidine—ADRA2A—medulla oblongata—malignant glioma	0.00103	0.0121	CbGeAlD
Clonidine—SLC22A1—brain—malignant glioma	0.00102	0.012	CbGeAlD
Clonidine—CYP2D6—telencephalon—malignant glioma	0.00101	0.012	CbGeAlD
Clonidine—Urticaria—Temozolomide—malignant glioma	0.001	0.00527	CcSEcCtD
Clonidine—Body temperature increased—Temozolomide—malignant glioma	0.000999	0.00525	CcSEcCtD
Clonidine—Abdominal pain—Temozolomide—malignant glioma	0.000999	0.00525	CcSEcCtD
Clonidine—ADRA1A—central nervous system—malignant glioma	0.000978	0.0115	CbGeAlD
Clonidine—SLC22A3—brain—malignant glioma	0.000975	0.0115	CbGeAlD
Clonidine—Hypersensitivity—Carmustine—malignant glioma	0.000964	0.00506	CcSEcCtD
Clonidine—ADRA1A—cerebellum—malignant glioma	0.000956	0.0113	CbGeAlD
Clonidine—ADRA2A—midbrain—malignant glioma	0.00094	0.0111	CbGeAlD
Clonidine—Asthenia—Carmustine—malignant glioma	0.000938	0.00493	CcSEcCtD
Clonidine—ADRA2C—central nervous system—malignant glioma	0.000932	0.011	CbGeAlD
Clonidine—Hypersensitivity—Temozolomide—malignant glioma	0.000931	0.00489	CcSEcCtD
Clonidine—ADRA2A—spinal cord—malignant glioma	0.000917	0.0108	CbGeAlD
Clonidine—ADRA2C—cerebellum—malignant glioma	0.000911	0.0108	CbGeAlD
Clonidine—Asthenia—Temozolomide—malignant glioma	0.000907	0.00476	CcSEcCtD
Clonidine—ABCB1—embryo—malignant glioma	0.000896	0.0106	CbGeAlD
Clonidine—Diarrhoea—Carmustine—malignant glioma	0.000895	0.0047	CcSEcCtD
Clonidine—Pruritus—Temozolomide—malignant glioma	0.000894	0.0047	CcSEcCtD
Clonidine—SLC22A5—cerebellum—malignant glioma	0.000873	0.0103	CbGeAlD
Clonidine—Dizziness—Carmustine—malignant glioma	0.000865	0.00454	CcSEcCtD
Clonidine—Diarrhoea—Temozolomide—malignant glioma	0.000865	0.00454	CcSEcCtD
Clonidine—Dizziness—Temozolomide—malignant glioma	0.000836	0.00439	CcSEcCtD
Clonidine—SLC6A2—brain—malignant glioma	0.000835	0.00986	CbGeAlD
Clonidine—Vomiting—Carmustine—malignant glioma	0.000832	0.00437	CcSEcCtD
Clonidine—Rash—Carmustine—malignant glioma	0.000825	0.00433	CcSEcCtD
Clonidine—Dermatitis—Carmustine—malignant glioma	0.000824	0.00433	CcSEcCtD
Clonidine—Headache—Carmustine—malignant glioma	0.000819	0.0043	CcSEcCtD
Clonidine—Vomiting—Temozolomide—malignant glioma	0.000804	0.00422	CcSEcCtD
Clonidine—CYP1A1—central nervous system—malignant glioma	0.000798	0.00942	CbGeAlD
Clonidine—Rash—Temozolomide—malignant glioma	0.000797	0.00418	CcSEcCtD
Clonidine—Dermatitis—Temozolomide—malignant glioma	0.000796	0.00418	CcSEcCtD
Clonidine—ABCB1—retina—malignant glioma	0.000793	0.00936	CbGeAlD
Clonidine—Headache—Temozolomide—malignant glioma	0.000792	0.00416	CcSEcCtD
Clonidine—Nausea—Carmustine—malignant glioma	0.000777	0.00408	CcSEcCtD
Clonidine—ADRA1A—brain—malignant glioma	0.000777	0.00917	CbGeAlD
Clonidine—Nausea—Temozolomide—malignant glioma	0.000751	0.00394	CcSEcCtD
Clonidine—ADRA2A—central nervous system—malignant glioma	0.000744	0.00878	CbGeAlD
Clonidine—ADRA2C—brain—malignant glioma	0.00074	0.00874	CbGeAlD
Clonidine—ABCB1—telencephalon—malignant glioma	0.000729	0.00861	CbGeAlD
Clonidine—ADRA2A—cerebellum—malignant glioma	0.000727	0.00858	CbGeAlD
Clonidine—SLC22A5—brain—malignant glioma	0.000709	0.00837	CbGeAlD
Clonidine—CYP1A1—brain—malignant glioma	0.000633	0.00748	CbGeAlD
Clonidine—ADRA2A—brain—malignant glioma	0.00059	0.00697	CbGeAlD
Clonidine—CYP3A4—central nervous system—malignant glioma	0.000585	0.00691	CbGeAlD
Clonidine—CYP2D6—central nervous system—malignant glioma	0.000576	0.0068	CbGeAlD
Clonidine—ABCB1—medulla oblongata—malignant glioma	0.000573	0.00676	CbGeAlD
Clonidine—CYP2D6—cerebellum—malignant glioma	0.000563	0.00665	CbGeAlD
Clonidine—ABCB1—midbrain—malignant glioma	0.000524	0.00618	CbGeAlD
Clonidine—ABCB1—spinal cord—malignant glioma	0.000511	0.00603	CbGeAlD
Clonidine—CYP2D6—brain—malignant glioma	0.000457	0.0054	CbGeAlD
Clonidine—ABCB1—central nervous system—malignant glioma	0.000414	0.00489	CbGeAlD
Clonidine—ABCB1—cerebellum—malignant glioma	0.000405	0.00478	CbGeAlD
Clonidine—ABCB1—brain—malignant glioma	0.000329	0.00388	CbGeAlD
Clonidine—SLC22A3—Metabolism—PIK3CA—malignant glioma	2.25e-05	9.17e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT2—malignant glioma	2.24e-05	9.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—malignant glioma	2.24e-05	9.16e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.24e-05	9.16e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—F2—malignant glioma	2.24e-05	9.15e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FN1—malignant glioma	2.24e-05	9.15e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	2.23e-05	9.13e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CB—malignant glioma	2.23e-05	9.1e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—malignant glioma	2.23e-05	9.1e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NCOR1—malignant glioma	2.22e-05	9.06e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAT—malignant glioma	2.21e-05	9.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—BAD—malignant glioma	2.21e-05	9.04e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—FGF2—malignant glioma	2.21e-05	9.03e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT2—malignant glioma	2.21e-05	9.02e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	2.2e-05	8.98e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	2.19e-05	8.96e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CAV1—malignant glioma	2.19e-05	8.93e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.18e-05	8.92e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.16e-05	8.84e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KDR—malignant glioma	2.16e-05	8.83e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	2.16e-05	8.81e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CB—malignant glioma	2.15e-05	8.8e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CD80—malignant glioma	2.15e-05	8.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.15e-05	8.77e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APC—malignant glioma	2.14e-05	8.76e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	2.14e-05	8.76e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL8—malignant glioma	2.14e-05	8.75e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	2.14e-05	8.72e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—malignant glioma	2.13e-05	8.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	2.12e-05	8.67e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGF—malignant glioma	2.12e-05	8.66e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	2.11e-05	8.62e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—malignant glioma	2.11e-05	8.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	2.11e-05	8.61e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.1e-05	8.59e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CD—malignant glioma	2.09e-05	8.56e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NCOR1—malignant glioma	2.09e-05	8.54e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—F2—malignant glioma	2.08e-05	8.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FN1—malignant glioma	2.08e-05	8.5e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	2.08e-05	8.49e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	2.08e-05	8.48e-05	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—malignant glioma	2.07e-05	8.45e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MDM2—malignant glioma	2.07e-05	8.45e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—FGF2—malignant glioma	2.06e-05	8.43e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.06e-05	8.43e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—RAF1—malignant glioma	2.06e-05	8.42e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—BAD—malignant glioma	2.06e-05	8.4e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—malignant glioma	2.05e-05	8.37e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL2—malignant glioma	2.05e-05	8.36e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	2.04e-05	8.33e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	2.04e-05	8.32e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—FGF2—malignant glioma	2.03e-05	8.3e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—BRAF—malignant glioma	2.02e-05	8.23e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	2.01e-05	8.22e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS1—malignant glioma	2.01e-05	8.21e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CD80—malignant glioma	2e-05	8.15e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APC—malignant glioma	1.99e-05	8.14e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	1.99e-05	8.14e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—malignant glioma	1.99e-05	8.13e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGF—malignant glioma	1.97e-05	8.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT2—malignant glioma	1.96e-05	8.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	1.96e-05	8e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.96e-05	7.99e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	1.95e-05	7.98e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTEN—malignant glioma	1.94e-05	7.93e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	1.94e-05	7.92e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—malignant glioma	1.94e-05	7.91e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	1.93e-05	7.9e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MDM2—malignant glioma	1.93e-05	7.89e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTP1—malignant glioma	1.93e-05	7.87e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTEN—malignant glioma	1.93e-05	7.87e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—RAF1—malignant glioma	1.93e-05	7.86e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.92e-05	7.84e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	1.91e-05	7.8e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	1.9e-05	7.78e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	1.9e-05	7.77e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	1.89e-05	7.74e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	1.89e-05	7.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	1.88e-05	7.68e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	1.88e-05	7.67e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAT—malignant glioma	1.88e-05	7.66e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	1.87e-05	7.66e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	1.87e-05	7.65e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—BCHE—malignant glioma	1.87e-05	7.64e-05	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	1.87e-05	7.63e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	1.87e-05	7.63e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—malignant glioma	1.86e-05	7.6e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—malignant glioma	1.85e-05	7.56e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	1.85e-05	7.56e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—malignant glioma	1.85e-05	7.55e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.85e-05	7.54e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	1.85e-05	7.54e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—malignant glioma	1.84e-05	7.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CB—malignant glioma	1.83e-05	7.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	1.82e-05	7.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	1.82e-05	7.41e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.81e-05	7.41e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—malignant glioma	1.81e-05	7.39e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CAV1—malignant glioma	1.81e-05	7.39e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	1.81e-05	7.38e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	1.8e-05	7.37e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	1.78e-05	7.26e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NCOR1—malignant glioma	1.77e-05	7.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	1.75e-05	7.15e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	1.75e-05	7.14e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	1.74e-05	7.13e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	1.74e-05	7.11e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	1.74e-05	7.1e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.73e-05	7.09e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	1.73e-05	7.06e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—malignant glioma	1.73e-05	7.05e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—malignant glioma	1.72e-05	7.04e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	1.72e-05	7.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	1.71e-05	7e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAV1—malignant glioma	1.7e-05	6.96e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	1.7e-05	6.95e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—malignant glioma	1.7e-05	6.94e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	1.7e-05	6.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.7e-05	6.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.69e-05	6.9e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.68e-05	6.87e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	1.68e-05	6.85e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.67e-05	6.83e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.67e-05	6.8e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—malignant glioma	1.66e-05	6.77e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—malignant glioma	1.65e-05	6.73e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.64e-05	6.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	1.63e-05	6.67e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	1.62e-05	6.63e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	1.61e-05	6.57e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—malignant glioma	1.6e-05	6.54e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	1.6e-05	6.53e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—malignant glioma	1.59e-05	6.5e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	1.58e-05	6.47e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.58e-05	6.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.58e-05	6.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—malignant glioma	1.58e-05	6.44e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.58e-05	6.43e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	1.57e-05	6.41e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.57e-05	6.41e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—malignant glioma	1.57e-05	6.4e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	1.57e-05	6.39e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.56e-05	6.39e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	1.56e-05	6.37e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	1.56e-05	6.35e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.55e-05	6.34e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.55e-05	6.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.53e-05	6.24e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.53e-05	6.23e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.51e-05	6.17e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.51e-05	6.16e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—malignant glioma	1.5e-05	6.12e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.49e-05	6.08e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	1.48e-05	6.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.47e-05	5.99e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	1.47e-05	5.99e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	1.45e-05	5.93e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—malignant glioma	1.45e-05	5.92e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAT—malignant glioma	1.45e-05	5.91e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—malignant glioma	1.45e-05	5.91e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—malignant glioma	1.44e-05	5.9e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAV1—malignant glioma	1.44e-05	5.9e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	1.44e-05	5.9e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.43e-05	5.84e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.43e-05	5.83e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.42e-05	5.8e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.42e-05	5.79e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	1.41e-05	5.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.4e-05	5.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.4e-05	5.73e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.39e-05	5.66e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	5.64e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—malignant glioma	1.37e-05	5.6e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.37e-05	5.58e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—malignant glioma	1.37e-05	5.58e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.36e-05	5.58e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	1.36e-05	5.55e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—malignant glioma	1.35e-05	5.51e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	1.34e-05	5.45e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.33e-05	5.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.33e-05	5.42e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	1.32e-05	5.39e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.32e-05	5.39e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.32e-05	5.37e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—malignant glioma	1.31e-05	5.37e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—malignant glioma	1.31e-05	5.36e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.3e-05	5.31e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.29e-05	5.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.28e-05	5.24e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.27e-05	5.19e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—malignant glioma	1.27e-05	5.19e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—malignant glioma	1.26e-05	5.16e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—malignant glioma	1.25e-05	5.11e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	1.25e-05	5.09e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.23e-05	5.01e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	1.23e-05	5.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.19e-05	4.87e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.19e-05	4.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—malignant glioma	1.19e-05	4.85e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.18e-05	4.82e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.18e-05	4.82e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.18e-05	4.82e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.16e-05	4.72e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.15e-05	4.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	1.15e-05	4.68e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.13e-05	4.61e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—malignant glioma	1.12e-05	4.57e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAV1—malignant glioma	1.11e-05	4.55e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.11e-05	4.55e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.11e-05	4.53e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—malignant glioma	1.11e-05	4.53e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.1e-05	4.48e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—malignant glioma	1.09e-05	4.46e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.09e-05	4.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.09e-05	4.45e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—malignant glioma	1.07e-05	4.38e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.07e-05	4.38e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—malignant glioma	1.03e-05	4.2e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.02e-05	4.17e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.02e-05	4.15e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.01e-05	4.14e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.01e-05	4.12e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1e-05	4.09e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1e-05	4.09e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—malignant glioma	9.99e-06	4.08e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—malignant glioma	9.8e-06	4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—malignant glioma	9.69e-06	3.96e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—malignant glioma	9.64e-06	3.94e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	9.36e-06	3.82e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	9.31e-06	3.8e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	9.21e-06	3.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—malignant glioma	9.09e-06	3.71e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—malignant glioma	9e-06	3.68e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.92e-06	3.65e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—malignant glioma	8.71e-06	3.56e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—malignant glioma	8.33e-06	3.4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	8.18e-06	3.34e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—malignant glioma	7.87e-06	3.22e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.78e-06	3.18e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—malignant glioma	7.71e-06	3.15e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—malignant glioma	7.7e-06	3.14e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	7.6e-06	3.11e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.25e-06	2.96e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—malignant glioma	6.72e-06	2.75e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—malignant glioma	6.29e-06	2.57e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—malignant glioma	6.14e-06	2.51e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—malignant glioma	5.92e-06	2.42e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—malignant glioma	5.02e-06	2.05e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.74e-06	1.94e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—malignant glioma	3.87e-06	1.58e-05	CbGpPWpGaD
